Current advantage of FK 506 in cadaveric kidney transplantation

Transplant Proc. 1996 Apr;28(2):1000-1.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Comparative Study
  • Multicenter Study

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Azathioprine / therapeutic use
  • Cadaver
  • Cyclosporine / therapeutic use
  • Cytomegalovirus Infections / epidemiology
  • Drug Therapy, Combination
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Kidney Transplantation / pathology
  • Methylprednisolone / therapeutic use
  • Patient Readmission
  • Survival Rate
  • Tacrolimus / therapeutic use*
  • Tissue Donors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Cyclosporine
  • Azathioprine
  • Tacrolimus
  • Methylprednisolone